已核实 DOI PubMed 相关产品: 106

Enhanced external counterpulsation: A new method to alleviate contrast-induced acute kidney injury

Journal 2022 · IF 2.261 · 发表于 2022 年 1 月 7 日
作者: Xiaocong Zhang,Chun Yao,Qunlin Xiao,Jiansheng Wu,Guifu Wu
阅读全文 在 PubMed 查看

摘要

Background Contrast-induced acute kidney injury (CI-AKI) is a common complication after exposure to contrast media. Renal ischaemia occurs in the initial stage of CI-AKI, however, there are very few effective measures to improve renal perfusion . Methods A total of 114 patients with an estimated glomerular filtration rate (eGFR) of 60–89 ml/min/1.73m 2 were randomly assigned to two groups: enhanced external counterpulsation (EECP) group ( N  = 57) and control group (N = 57). Two hours after contrast exposure, EECP group received EECP treatment for 1 h while no intervention was performed control group. The primary outcome was the incidence of serum cystatin C concentration to 10% above the baseline concentration at 24 h after contrast administration. The secondary outcomes were the incidence of CI-AKI (defined as an increase in serum creatinine concentration to ≥0.5 mg/dl or by 25% compare to the baseline after contrast exposure), contrast clearance and adverse clinical events. Results The primary outcome was observed in 26 patients (6 EECP and 20 control; 11% vs. 35%; P  = 0.002). CI-AKI occurred in four patients (0 EECP and 4 control; 0% vs. 7%; P  = 0.042). The clearance rate of iopromide in the initial 3 h was significantly different between EECP and control group (59.92 ± 8.84 vs 46.80 ± 9.26 ml/min/1.73 m 2 ; P  < 0.001). No adverse clinical events were observed in this study. Conclusions This study demonstrates that EECP increases the contrast clearance and may have an effect in reducing the risk of CI-AKI. The study has been registered in Chinese Clinical Trial Registry (ChiCTR 2,000,039,190).

本研究中使用的阿拉丁产品

106 款产品在本文中被引用